British Society for Rheumatology guideline on management of adult and juvenile onset Sjogren disease

Elizabeth J. Price*, Stuart Benjamin, Michele Bombardieri, Simon Bowman, Sara Carty, Coziana Ciurtin, Bridget Crampton, Annabel Dawson, Benjamin A. Fisher, Ian Giles, Peter Glennon, Monica Gupta, Katie Hackett, Genevieve Larkin, Wan-Fai Ng, A.V. Ramanan, Saad Rassam, Saaeha Rauz, Smith Guy, Nurhan SutcliffeAnwar R. Tappuni, Stephen B. Walsh

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Sjogren disease (SD) is a chronic, auto-immune disease of unknown aetiology with significant impact on quality of life (QoL). Although dryness (sicca) of the eyes and mouth are the classically described features, dryness of other mucosal surfaces and systemic manifestations are common. The key management aim should be to empower the individual to manage their condition; conserving, replacing and stimulating secretions; preventing damage and suppressing systemic disease activity.

This guideline builds on, and widens the recommendations developed for the first guideline published in 2017. We have included advice on the management of children and adolescents where appropriate to provide a comprehensive guideline for UK based rheumatology teams.
Original languageEnglish
Article numberkeae152
Pages (from-to)1-31
Number of pages31
Early online date16 Apr 2024
Publication statusE-pub ahead of print - 16 Apr 2024

Cite this